Seven-tesla (7T) magnetic resonance imaging (MRI) has become an important tool to investigate noninvasively the cerebral pathology affecting patients with multiple sclerosis (MS). Indeed, the superior image resolution and contrast achieved at 7T has allowed researchers to study brain lesions in great detail and advance our understanding of the formation and extent of these lesions throughout the evolution of the disease.^1,2 However, the recent United States Food and Drug Administration (FDA) approval of commercially available 7T MRI scanners has been met with mixed expectations from clinicians. The current divide between proponents and skeptics of this high-end imaging device is perfectly captured by this Controversy section.

中文翻译：

---

7 Tesla MRI很快将有助于指导多发性硬化症中心的临床实践–评论

七特斯拉（7T）磁共振成像（MRI）已成为研究非侵入性影响多发性硬化症（MS）患者的脑病理的重要工具。的确，在7T时达到的卓越图像分辨率和对比度使研究人员能够更详细地研究脑部病变，并在疾病发展的整个过程中加深我们对这些病变的形成和程度的了解。^1,2但是，最近美国食品药品监督管理局（FDA）批准了商用7T MRI扫描仪，临床医生对此的期望值不一。此争议部分完美地描述了高端成像设备的支持者和怀疑者之间的分歧。